231 related articles for article (PubMed ID: 16372814)
1. Intravenous dexamethasone-cyclophosphamide pulse therapy in comparison with oral methylprednisolone-azathioprine therapy in patients with pemphigus: results of a multicenter prospectively randomized study.
Rose E; Wever S; Zilliken D; Linse R; Haustein UF; Bröcker EB
J Dtsch Dermatol Ges; 2005 Mar; 3(3):200-6. PubMed ID: 16372814
[TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of dexamethasone-cyclophosphamide pulse therapy in pemphigus.
Kanwar AJ; Kaur S; Thami GP
Dermatology; 2002; 204(3):228-31. PubMed ID: 12037452
[TBL] [Abstract][Full Text] [Related]
3. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus.
Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Luger TA
Arch Dermatol; 2006 Nov; 142(11):1447-54. PubMed ID: 17116835
[TBL] [Abstract][Full Text] [Related]
4. Current regimen of pulse therapy for pemphigus: minor modifications, improved results.
Pasricha JS;
Indian J Dermatol Venereol Leprol; 2008; 74(3):217-21. PubMed ID: 18583786
[TBL] [Abstract][Full Text] [Related]
5. Methylprednisolone pulse therapy plus adjuvant therapy for pemphigus vulgaris: an analysis of 10 years' experience on 312 patients.
Gheisari M; Faraji Z; Dadras MS; Nasiri S; Robati RM; Moravvej H; Tehranchinia Z; Ghalamkarpour F; Namazi N; Nobari NN
Dermatol Ther; 2019 Sep; 32(5):e13057. PubMed ID: 31400243
[TBL] [Abstract][Full Text] [Related]
6. The use of oral cyclophosphamide with dexamethasone pulse therapy in the treatment of pemphigus vulgaris.
Momeni AZ; Iraji F; Aminjavaheri M; Emami MR; Momeni A
J Dermatolog Treat; 2007; 18(5):275-8. PubMed ID: 17852639
[TBL] [Abstract][Full Text] [Related]
7. Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
Mentink LF; Mackenzie MW; Tóth GG; Laseur M; Lambert FP; Veeger NJ; Cianchini G; Pavlovic MD; Jonkman MF
Arch Dermatol; 2006 May; 142(5):570-6. PubMed ID: 16702494
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.
Olszewska M; Kolacinska-Strasz Z; Sulej J; Labecka H; Cwikla J; Natorska U; Blaszczyk M
Am J Clin Dermatol; 2007; 8(2):85-92. PubMed ID: 17428113
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone-cyclophosphamide pulse therapy for pemphigus.
Pasricha JS; Khaitan BK; Raman RS; Chandra M
Int J Dermatol; 1995 Dec; 34(12):875-82. PubMed ID: 8647673
[TBL] [Abstract][Full Text] [Related]
10. Pulse versus oral methylprednisolone therapy in pemphigus vulgaris.
Shahidi-Dadras M; Karami A; Toosy P; Shafiyan A
Arch Iran Med; 2007 Jan; 10(1):1-6. PubMed ID: 17198445
[TBL] [Abstract][Full Text] [Related]
11. [Prolonged complete clinical remission in patients with severe pemphigus vulgaris after cycles of intravenous cyclophosphamide].
España Alonso A; Panizo C; Fernández S; Marquina M; Pretel M; Aguado L; Sánchez-Ibarrola A
Actas Dermosifiliogr; 2009 Mar; 100(2):113-20. PubMed ID: 19445875
[TBL] [Abstract][Full Text] [Related]
12. Pulse glucocorticoid therapy. The 'big shot' revisited.
Roujeau JC
Arch Dermatol; 1996 Dec; 132(12):1499-502. PubMed ID: 8961881
[TBL] [Abstract][Full Text] [Related]
13. Oral pemphigus: long term behaviour and clinical response to treatment with deflazacort in sixteen cases.
Mignogna MD; Lo Muzio L; Mignogna RE; Carbone R; Ruoppo E; Bucci E
J Oral Pathol Med; 2000 Apr; 29(4):145-52. PubMed ID: 10766391
[TBL] [Abstract][Full Text] [Related]
14. High-dose intravenous 'pulse' methylprednisone in the treatment of severe oropharyngeal pemphigus: a pilot study.
Mignogna MD; Lo Muzio L; Ruoppo E; Fedele S; Lo Russo L; Bucci E
J Oral Pathol Med; 2002 Jul; 31(6):339-44. PubMed ID: 12201245
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe pemphigus with a combination of immunoadsorption, rituximab, pulsed dexamethasone and azathioprine/mycophenolate mofetil: a pilot study of 23 patients.
Kasperkiewicz M; Shimanovich I; Meier M; Schumacher N; Westermann L; Kramer J; Zillikens D; Schmidt E
Br J Dermatol; 2012 Jan; 166(1):154-60. PubMed ID: 21910700
[TBL] [Abstract][Full Text] [Related]
16. Steroid-pulse therapy in pemphigus vulgaris long term follow-up.
Chryssomallis F; Dimitriades A; Chaidemenos GC; Panagiotides D; Karakatsanis G
Int J Dermatol; 1995 Jun; 34(6):438-42. PubMed ID: 7657447
[TBL] [Abstract][Full Text] [Related]
17. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
Werth VP
Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
[TBL] [Abstract][Full Text] [Related]
18. Twelve-year clinico-therapeutic experience in pemphigus: a retrospective study of 54 cases.
Mahajan VK; Sharma NL; Sharma RC; Garg G
Int J Dermatol; 2005 Oct; 44(10):821-7. PubMed ID: 16207182
[TBL] [Abstract][Full Text] [Related]
19. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone-cyclophosphamide pulse therapy in pemphigus.
Kaur S; Kanwar AJ
Int J Dermatol; 1990 Jun; 29(5):371-4. PubMed ID: 2361797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
